Table 1.
Dietary intake after 1 year of treatment with orlistat
| All participants (n = 63) |
High attendance group (n = 31) |
Low attendance group (n = 32) |
P* | |
|---|---|---|---|---|
| Energy intake (kJ) | ||||
| 1 year | 9229 ± 2304† | 8747 ± 2033 | 9696 ± 2483 | |
| Change‡ | 178 [-366, 722] § | -57 ± 1618 | 406 ± 2661 | 0.409 |
| Energy density (kJ/g) | ||||
| 1 year | 5.3 ± 1.5 | 4.7 ± 1.2 | 5.9 ± 1.5 | |
| Change | 0.5 [0.2, 0.7] | 0.1 ± 0.9 | 0.8 ± 1.0 | 0.008 |
| Fat (E%) | ||||
| 1 year | 29.7 ± 7.3 | 27.3 ± 6.5 | 32.0 ± 7.4 | |
| Change | 1.7 [-0.2, 3.6] | 0.2 ± 6.6 | 3.2 ± 8.5 | 0.117 |
| Saturated fat (E%) | ||||
| 1 year | 10.1 ± 3.7 | 8.6 ± 2.4 | 11.5 ± 4.1 | |
| Change | 1.2 [0.4, 2.0] | 0.7 ± 1.7 | 1.7 ± 4.2 | 0.201 |
| Monounsaturated fat (E%) | ||||
| 1 year | 10.1 ± 3.7 | 8.6 ± 2.4 | 11.5 ± 4.1 | |
| Change | -1.3 [-2.2, -0.3] | -2.6 ± 2.9 | 0 ± 4.5 | 0.009 |
| Polyunsaturated fat (E%) | ||||
| 1 year | 5.4 ± 1.7 | 5.3 ± 2.1 | 5.4 ± 1.3 | |
| Change | 0 [-0.5, 0.5] | -0.3 ± 2.2 | 0.3 ± 1.4 | 0.169 |
| Protein (E%) | ||||
| 1 year | 17.4 ± 2.7 | 18.3 ± 2.5 | 16.5 ± 2.6 | |
| Change | 0 [-0.6, 0.8] | 0.8 ± 3.3 | 0.3 ± 1.4 | 0.051 |
| Carbohydrate (E%) | ||||
| 1 year | 47.7 ± 6.5 | 48.7 ± 6.3 | 46.7 ± 6.5 | |
| Change | -1.9 [-3.7, -0.2] | -0.4 ± 5.9 | -3.4 ± 1.4 | 0.089 |
| Fiber (g/MJ) | ||||
| 1 year | 3.9 ± 1.4 | 4.3 ± 1.5 | 3.5 ± 1.2 | |
| Change | -0.3 [-0.6, -0.1] | -0.1 ± 1.2 | -0.5 ± 0.8 | 0.143 |
* Comparison of changes between the high and low attendance group (unpaired t-test). The subjects in the high attendance group attended more group sessions than the mean which was 9.34 sessions and the subjects in the low attendance group attended = 9.34 sessions.
† Mean ± SD ‡ Changes are calculated as the difference between 1 year and the start of orlistat. § Mean; 95% CI in brackets.